We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automatic Blood Cell Analyzer Detects Malaria Parasites

By LabMedica International staff writers
Posted on 15 Dec 2011
An automated hematology analyzer can detect malaria parasites during routine complete blood counts.

The analyzer can sensitively detect and accurately monitor an infection of Plasmodium vivax in blood samples, as well as being an effective screening test for the parasite.

Scientists at the Catholic University of Korea (Seoul, Korea) retrospectively analyzed a total of 1,761 complete blood count (CBC) samples generated by the automated hematology analyzer. More...
The sample pool contained 123 samples from 52 P. vivax malaria patients and 1,504 nonmalarial samples including 509 patients with leucopenia whose white blood cell count was less than 2,000/μL, and 134 normal subjects.

The P. vivax malaria samples exhibited easily recognizable typical malaria signals on the nucleated red blood cell (nRBC) plots with a sensitivity of 100% using the automatic blood cell analyzer, the DxH 800. All 1,504 samples without P. vivax infection were negative for malaria signal giving a specificity of 100%. The size of P. vivax malaria signals correlated approximately with the parasite burden.

The gold standard of P. vivax-malaria diagnosis is the microscopy of blood smears. Although microscopy is a rapid, cost-effective, and readily applicable method, it has many disadvantages, including low sensitivity, specificity, and precision. Therefore, there is a clear need for an effective screening test for P. vivax-malaria detection in both high-prevalence areas and developed countries.

The automated hematology analyzer DxH 800 (Beckman Coulter Inc., Miami, FL, USA) provided very sensitive and specific, easily recognizable P. vivax-malaria signals on routine CBC without need for the additional reagents or special procedures. The study was published online on November 11, 2011, in the International Journal of Laboratory Hematology.

Related Links:
Catholic University of Korea
Beckman Coulter Inc.




New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Electrolyte Analyzer
BKE-B
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.